HomeBUSINESS
BUSINESS

Alcon Pharma Reorganizes Marketing System to Boost Market Shares of Major Products including Lucentis
(Mar.5.2018)

Alcon Pharma President Shoichiro Ogawa
The ophthalmic drug maker Alcon Pharma has reorganized its marketing system by merging its retina division and glaucoma/extraocular division into a single division. With the reorganization, the company intends to boost market shares of its major products including the age-related macular degeneration (AMD) treatment Lucentis (ranibizumab) ...
(LOG IN FOR FULL STORY)